SUBSCRIBE
SUBSCRIBE
News   FDA

Europe Approves Wyeth’s Enbrel for Psoriasis in Children

January 8, 2009 | 
1 min read
LONDON, Jan 8 (Reuters) - Wyeth's established drug Enbrel has been approved by the European Commission as the first biologic treatment for children with severe plaque psoriasis, the U.S. company said on Thursday.
FDA Approvals Europe
MORE ON THIS TOPIC
Washington, D.C., USA- January 13, 2020: FDA Sign at its headquarters in Washington DC. The Food and Drug Administration (FDA or USFDA) is a federal agency of the USA.
Policy
FDA Eyes Higher User Fees for Companies Holding Phase I Studies Abroad
December 4, 2025
 · 
2 min read
 · 
Tristan Manalac
Vaccines
FDA To Provide Further Data on 10 Alleged Pediatric Deaths Linked to COVID-19 Vaccines By End of Month
December 4, 2025
 · 
2 min read
 · 
Tristan Manalac
Silver Spring, MD, USA 11/10/2020: Exterior view of the headquarters of US Food and Drug Administration (FDA). This federal agency approves medications, vaccines and food additives for human use.
Regulatory
COVID Contrarian Tracy Beth Høeg Named as FDA’s Acting CDER Chief
December 4, 2025
 · 
2 min read
 · 
Tristan Manalac
FDA
New Approach Methodologies: Redefining Animal Testing Alternatives
December 4, 2025
 · 
1 min read
 · 
BioSpace Insights